Mount Sinai - Icahn School of Medicine — New York, New York

Mount Sinai - Icahn School of Medicine is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai - Icahn School of Medicine has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Pemphigus Vulgaris, Glioblastoma Multiforme, Parkinson Disease.

Sponsors: Cabaletta Bio, NovoCure Ltd., Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai - Icahn School of Medicine?

Mount Sinai - Icahn School of Medicine has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai - Icahn School of Medicine conducted?

Mount Sinai - Icahn School of Medicine has 4 clinical trials on record, with 1 currently active. Their work covers Pemphigus Vulgaris, Glioblastoma Multiforme, Parkinson Disease.

Is Mount Sinai - Icahn School of Medicine accredited by Crixeo Health?

Mount Sinai - Icahn School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai - Icahn School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.